Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis: results from the retained organic solutes and clinical outcomes (ROSCO) investigators

[1]  Raymond Vanholder,et al.  Normal and pathologic concentrations of uremic toxins. , 2012, Journal of the American Society of Nephrology : JASN.

[2]  Yang Qiu,et al.  'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  Christopher T. Chan,et al.  The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. , 2011, Kidney international.

[4]  Z. Massy,et al.  [Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease]. , 2011, Nephrologie & therapeutique.

[5]  N. Jourde-Chiche,et al.  Vascular Incompetence in Dialysis Patients—Protein‐Bound Uremic Toxins and Endothelial Dysfunction , 2011, Seminars in dialysis.

[6]  Z. Massy,et al.  [Plasma malondialdehyde may not predict mortality in patient with chronic kidney disease]. , 2011, Nephrologie & therapeutique.

[7]  G. Beck,et al.  In-center hemodialysis six times per week versus three times per week. , 2010, The New England journal of medicine.

[8]  Chih-jen Wu,et al.  Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  K. Verbeke,et al.  p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[10]  T. Meyer,et al.  Methylamine clearance by haemodialysis is low. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  Z. Massy,et al.  Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  T. Meyer,et al.  Derivatization of Methylamine and Ethylamine Followed by LC and Fluorescence Detection for Measurement of Urinary Clearance , 2010 .

[13]  Frits R Rosendaal,et al.  Cardiovascular and noncardiovascular mortality among patients starting dialysis. , 2009, JAMA.

[14]  Z. Massy,et al.  Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[15]  T. Meyer,et al.  Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  J. Jankowski,et al.  A bench to bedside view of uremic toxins. , 2008, Journal of the American Society of Nephrology : JASN.

[17]  C. Ghelardini,et al.  Methylamine‐dependent release of nitric oxide and dopamine in the CNS modulates food intake in fasting rats , 2007, British journal of pharmacology.

[18]  K. Verbeke,et al.  Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. , 2006, Kidney international.

[19]  T. Meyer,et al.  Removal of P-cresol sulfate by hemodialysis. , 2005, Journal of the American Society of Nephrology : JASN.

[20]  T. Meyer,et al.  The clearance of protein-bound solutes by hemofiltration and hemodiafiltration. , 2005, Kidney international.

[21]  C. Ghelardini,et al.  Methylamine, but not ammonia, is hypophagic in mouse by interaction with brain Kv1.6 channel subtype , 2004, British journal of pharmacology.

[22]  N. Powe,et al.  Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  N. Powe,et al.  Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. , 2004, JAMA.

[24]  M. Rocco,et al.  Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  G. Banchelli,et al.  Methylamine and benzylamine induced hypophagia in mice: Modulation by semicarbazide‐sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels , 2001, British journal of pharmacology.

[26]  M. Sandra Wood,et al.  Health care financing administration , 2000 .

[27]  L. Agodoa,et al.  United States Renal Data System (USRDS). , 2000, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[28]  R. Foley,et al.  Epidemiology of cardiovascular disease in chronic renal disease , 2000 .

[29]  L H Kuller,et al.  Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[30]  E. N. Allott,et al.  UREMIA , 1963 .